
Rep. Katie Porter @RepKatiePorter
Internal documents show that Big Pharma is specifically targeting the U.S. market because Medicare can’t negotiate. Taxpayers lost more than $25 billion over a 5 year period because of this policy. It's fiscally irresponsible not to let Medicare negotiate drug prices. (3/8) — PolitiTweet.org